One Fin Capital Management LP Immunovant, Inc. Transaction History

One Fin Capital Management LP

  • $146 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$7.01 - $11.37 $4.29 Million - $6.96 Million
-612,497 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$9.4 - $16.85 $564,000 - $1.01 Million
60,000 Added 10.86%
612,497 $6.47 Million
Q1 2021

May 17, 2021
BUY
$13.08 - $49.6 $7.23 Million - $27.4 Million
552,497 New
552,497 $8.86 Million

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track One Fin Capital Management LP Portfolio

Follow One Fin Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One Fin Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on One Fin Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email